Topical corticosteroids market to reach $13.13 billion by 2030 at 7.4% CAGR, driven by rising incidence of chronic skin disorders.
Read More
Tardive dyskinesia therapeutics market to reach $4.39 billion by 2030 at 7.0% CAGR, driven by increasing prevalence of mental health disorders.
Read More
Topical antifungals market to reach $8.23 billion by 2030 at 6.4% CAGR, driven by increasing prevalence of skin diseases caused by environmental factors.
Read More
Tacrolimus market to reach $9.06 billion by 2030 at 5.2% CAGR, driven by rising number of organ transplant procedures and growing geriatric population.
Read More
Tofacitinib market to reach $6.53 billion by 2030 at 14.0% CAGR, driven by increasing number of patients with inflammatory bowel disease.
Read More
T cell surface glycoprotein cd3 epsilon chain market to reach $1.89 billion by 2030 at 8.8% CAGR, driven by increasing prevalence of autoimmune diseases.
Read More
Tnf alpha inhibitors market to reach $50.58 billion by 2030 at 3.0% CAGR, driven by increasing geriatric population susceptible to autoimmune disorders.
Read More
Tissue regeneration scaffold market to reach $5.58 billion by 2030 at 16.3% CAGR, driven by growing number of trauma cases from accidents and injuries.
Read More
Tissue plasminogen activator market to reach $5.66 billion by 2030 at 8.6% CAGR, driven by rising prevalence of lifestyle-related disorders.
Read More
Tissue engineering for wound care market to reach $13.61 billion by 2030 at 14.4% CAGR, driven by increasing prevalence of musculoskeletal disorders.
Read More